Martha Shadan

Martha Shadan discloses dealings in 2 companies, chiefly Lemaitre Vascular Inc and CVRx, Inc. Over a trading history stretching from 12 December 2022 to 1 June 2026, the count stands at 23 filings.

Every open-market trade on record is a sale: 2 sales worth €143k. Other entries cover 8 share grants and 13 option exercises.

Most recently, on 3 June 2026, the filings show a share grant in CVRx, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.